Methyl 1-(4-chlorobenzyl)-2-methyl-6-oxo-1,4,5,6-tetrahydropyridine-3-carboxylate

Catalog No. :
ACIGBA217
CAS No. :
338748-81-5
Molecular Formula :
C15H16ClNO3
Molecular Weight :
293.75

IUPAC Name:methyl 1-(4-chlorobenzyl)-2-methyl-6-oxo-1,4,5,6-tetrahydropyridine-3-carboxylate

Methyl 1-(4-chlorobenzyl)-2-methyl-6-oxo-1,4,5,6-tetrahydropyridine-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg95%$365.00Login to see priceInquiryInquiry
250mg95%$462.00Login to see priceInquiryInquiry
1g95%$600.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 1-(4-chlorobenzyl)-2-methyl-6-oxo-1,4,5,6-tetrahydropyridine-3-carboxylate
IUPAC Namemethyl 1-(4-chlorobenzyl)-2-methyl-6-oxo-1,4,5,6-tetrahydropyridine-3-carboxylate
MDL No.MFCD00975047
Molecular FormulaC15H16ClNO3
Molecular Weight293.75
SMILESO=C(C(CC1)=C(C)N(CC2=CC=C(Cl)C=C2)C1=O)OC
InChI KeyJUYUWPOLWQZNGA-UHFFFAOYSA-N
SynonymMETHYL 1-(4-CHLOROBENZYL)-2-METHYL-6-OXO-1,4,5,6-TETRAHYDRO-3-PYRIDINECARBOXYLATE;3-Pyridinecarboxylic acid, 1-[(4-chlorophenyl)methyl]-1,4,5,6-tetrahydro-2-methyl-6-oxo-, methyl ester;Methyl 1-[(4-chlorophenyl)methyl]-2-methyl-6-oxo-1,4,5,6-tetrahydropyridine-3-carboxylate
CAS No.338748-81-5

Synthetic Route by SureRoute

1. ACIGBA217 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIGBA217 route product structure diagram
    ACIGBA217338748-81-5
Inquiry

2. ACIGBA217 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIGBA217 route product structure diagram
    ACIGBA217338748-81-5
Inquiry

Comments (0)